
Cosmos Health Inc.: quarterly results
Price
$2.95
November 18, 2026
What Ploutos Investor adds for Cosmos Health
Part of Ploutos Investor, €9.99 a month
- The full history: 13 fiscal years, from 2013
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 1,325% since Aug 18, 2026, when the 10-Q these figures come from was filed ($0.21 then, $2.95 on Nov 18, 2026). The figures date from before that move.10-Q
- The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Results, quarter by quarter
When the company put out each quarter's results (its 8-K, item 2.02), what they showed against the same quarter a year before, and how the stock moved on the first session after.
Next results
last Oct 22, 2026next Jan 15, 2027
An estimate from when it has reported before, and the timing has varied a little. The company announces the date itself.
The first session after results
±4.8%average move, either way
2 times upof the last 42 times down
Largest: -10.0% on Oct 22, 2026 (Q3 2026).
How the stock moved after each release
The close of the first session after the results against the close before them.
COSM that sessionS&P 500 the same day
Every release
Revenue and diluted EPS of the quarter reported, with the change against the same quarter a year before.
- Q3 2026Stock, next session-10.0%
- –Stock, next session+4.2%
- Q2 2026Stock, next session+4.2%
- Q1 2026Stock, next session-0.8%
| Quarter | Released | Revenue | EPS | Stock, next session | S&P 500 | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | Oct 22, 2026before the close | with the 10-Q | with the 10-Q | -10.0% | -1.2% | 8-K |
| – | Oct 9, 2026after the close | – | – | +4.2% | -0.1% | 8-K |
| Q2 2026 | Aug 20, 2026after the close | $19M+28.8% | -$0.10 | +4.2% | +0.4% | 8-K |
| Q1 2026 | May 22, 2026before the close | $18M+30.7% | -$0.06 | -0.8% | +0.4% | 8-K |
Every release
COSM's results days and the share's move after each, from Q3 2020 to Q1 2026, 22 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 8 quarters.
and 17 more, back to Q3 2020
Times are the SEC's acceptance of the 8-K, in New York time: before 16:00 the market traded on it that day, after it the next day. A move on a results day has other causes too, and says nothing about the next one. "With the 10-Q": the quarter was just released and its figures reach the SEC's structured data with the 10-Q, a few weeks later. The press release is linked in the 8-K. A dash in a quarter's figures: the SEC's structured data does not have them.
The full analysis
What do Cosmos Health's filings show?
The results say what Cosmos Health reported. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.